Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals

NCT02602496
completednot_applicable

Effects of Whole Grain Rye on Metabolic Risk Markers and Mood

NCT03275948
unknownnot_applicable

The Effect of Whole Grain on Gut Microbiome and Metabolic Health

NCT01731366

Clinical Trials (3)

Showing 3 of 3 trials
NCT02602496Not Applicable

Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals

Completed
NCT03275948Not Applicable

Effects of Whole Grain Rye on Metabolic Risk Markers and Mood

Completed
NCT01731366Not Applicable

The Effect of Whole Grain on Gut Microbiome and Metabolic Health

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3